Dentium덴티움

Dentium's profits have fallen sharply from their 2023 peak, though the shares have risen 11% over the past month.

Dentium, a Korean maker of dental implants and digital dentistry equipment, is earning far less than it did in 2022 and 2023. Trailing twelve-month revenue is about ₩348B with an operating margin of 20% and net margin of 8.7%, and the company is trying to diversify into hydrogen fuel cell components. The share price of ₩40,700 sits near the lower half of its 52-week range of ₩35,000 to ₩60,600.

What stands out

• Revenue fell 15% in 2025 to about ₩346B, and operating income dropped from ₩138B in 2023 to ₩64B in 2025.
• Trailing twelve-month net income is ₩30B, against ₩97B in 2023, and return on equity is 5.2%.
• Free cash flow is negative at about -₩17B over the period to H1 2026, and borrowings of ₩292B exceed cash of ₩62B.
• Valuation looks low on earnings, with a P/E of 11.7 and P/B of 0.6, and the dividend yield is 1.5%; the data gives a DCF base value of ₩137,155, but this is a model output, not a forecast.
• Foreign ownership fell from 14.6% to 10.1% over about 60 days, while the stock was up 11.2% over one month and down 27.3% over one year.

What to watch

• Next periodic results, since the data shows amended reports for 2024 and 2025 filed in late September 2026 and the H1 2026 half-year report was filed in August.
• Lawsuit filings from August and September 2026; the data does not say what these concern or their potential impact.
• Progress of the hydrogen fuel cell (SOFC) plans and the Vietnam production facility, which the data does not show in financial terms yet.